Taipaleenmäki, H., Farina, N. H., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S., & Lian, J. B. (2016). Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells. Oncotarget.

Taipaleenmäki, Hanna, Nicholas H. Farina, Andre J. van Wijnen, Janet L. Stein, Eric Hesse, Gary S. Stein, and Jane B. Lian. "Antagonizing MiR-218-5p Attenuates Wnt Signaling and Reduces Metastatic Bone Disease of Triple Negative Breast Cancer Cells." Oncotarget 2016.

Taipaleenmäki, Hanna, et al. "Antagonizing MiR-218-5p Attenuates Wnt Signaling and Reduces Metastatic Bone Disease of Triple Negative Breast Cancer Cells." Oncotarget 2016.